All Research News articles – Page 68
-
NewsChinese medicinal fungus shows promise in treating idiopathic pulmonary fibrosis
A recent study from China has reported that Cordyceps sinensis (CS), a traditional Chinese medicinal fungus, can ameliorate idiopathic pulmonary fibrosis (IPF) in mice by inhibiting mitochondrion-mediated oxidative stress.
-
NewsMadrid study shows decrease in active hepatitis C infection among risk groups
A study conducted through a mobile screening unit in Madrid, Spain from 2017 to 2023 found that active hepatitis C virus (HCV) infection decreased from 23% to 6% in that period among people who use drugs (PWUD) that visited the unit.
-
NewsScientists identify key protein behind spread of shingles virus
Scientists have discovered a new evasion strategy used by the varicella zoster virus, which causes chickenpox and shingles, that may allow it to affect tissues far from the original site of infection.
-
NewsOysters succumb to deadly viral outbreak - but only at higher water temperatures
Oyster farmers in San Diego Bay will be able to protect them from deadly viral outbreaks by growing them at times when the water is cooler, thanks to the findings of a new study.
-
NewsScientists unveil evidence for new groups of methane-producing organisms
A team of scientists has provided the first experimental evidence that two new groups of microbes thriving in thermal features in Yellowstone National Park produce methane.
-
NewsNew study determines incidence of and risk factors for hepatitis C virus reinfection among men with HIV
A new study provides new perspectives on transmission of hepatitis C virus (HCV), a virus that infects the liver and can be transmitted during injection of drugs, among men who have sex with men (MSM).
-
NewsMild COVID-19 can cause long-term cognitive losses
Although the damage caused by SARS-CoV-2 was most intense among those who had severe COVID-19, some had memory loss and attention deficit more than 18 months after being infected, even though they had not needed to be hospitalized.
-
NewsExploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international clinical trial primarily funded by the National Institutes of Health (NIH). There ...
-
NewsWearable health sensors are a powerful tool in disease detection
When seemingly healthy people receive an alert from a wearable sensor telling them they might have a respiratory virus, only a quarter of people follow up such an alert with an at-home viral test, according to a new study.
-
NewsFecal matter transplant helped patients with gastrointestinal cancers overcome resistance to immunotherapy treatment
Findings from a small, proof-of-concept clinical trial have suggested that fecal microbiota transplants (FMTs) can boost the effectiveness of immunotherapy in a range of gastrointestinal cancers.
-
NewsNext generation biosensor reveals gibberellin’s critical role in legume nitrogen-fixation
Researchers have identified the specific times and location where gibberellin (GA governs) the initiation, growth and function of nitrogen-fixing root nodules.
-
NewsBreakthrough study seeks functional cure for HIV
Researchers in George Mason University’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study in Nature’s Gene Therapy that found an HIV-like virus particle that could cease the need for lifelong medications. Source: Photo by Evan Cantwell/Office of University Branding/George ...
-
NewsScientists uncover genes that contribute to severe COVID-19 susceptibility
Researchers confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women.
-
NewsDual action antibiotic could make bacterial resistance nearly impossible
A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research
-
NewsNew agent effective against drug-resistant malaria parasites
Scientists have developed a promising new antimalarial agent, DIF-1(+3), which is a derivative of Dictyostelium differentiation-inducing factor-1 (DIF-1).
-
NewsLong-acting injectable cabotegravir for HIV prevention is safe in pregnancy
Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study.
-
NewsMini lungs make major COVID-19 discoveries possible
Scientists infect miniature lung organoids with the virus responsible for COVID-19, revealing new ways in which the infection spreads and suggesting potential treatments.
-
NewsBoosting plant health: the role of gene exchange with bacteria
Scientists have discovered 75 genes that were transferred between small, fast-growing plants (Arabidopsis thaliana) and its bacterial companions, influencing key processes like carbohydrate metabolism and hormone synthesis.
-
NewsIsolated viral load test may generate false positive results for people using long-acting PrEP
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect HIV in a multi-country study.
-
NewsNew study confirms mammal-to-mammal avian flu spread
A new study provides evidence that a spillover of avian influenza from birds to dairy cattle across several U.S. states has now led to mammal-to-mammal transmission – between cows and from cows to cats and a raccoon.